IP Library Assignment 014287/0567
Patent Assignment
Reel/Frame 014287/0567

Merger

Recorded: 2004-01-27 Pages: 13
Assignor
TRIANGLE PHARMACEUTICALS, INC.
Executed: 2003-12-12
Assignee
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Properties (23)
Use of Mkc-442 in Combination with Other Antiviral Agents
Patent: 6,410,546 →
Application: 09/056,548 →
Method of Manufacture of 1,3-Oxathiolane Nucleosides
Patent: 6,215,004 →
Application: 09/373,891 →
Combination Therapy to Treat Hepatitis B Virus
Patent: 6,528,515 →
Application: 09/432,247 →
Method of Manufacture of 1,3-Oxathiolane Nucleosides
Patent: 6,518,425 →
Application: 09/570,885 →
Non-Homogeneous Systems for the Resolution of Enantiomeric Mixtures
Patent: 6,979,561 →
Application: 09/585,166 →
Method of Manufacture of 1, 3-Oxathiolane Nucleosides
Patent: 6,576,776 →
Application: 09/669,806 →
DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor
Application: 10/023,636 →
Publication: US 2002/0173491
Polymorphic and Other Crystalline Forms Cis-Ftc
Patent: 6,723,728 →
Application: 10/086,830 →
Publication: US 2003/0060645
Process for the Preparation of 2'-Halo-Beta-L-Arabinofuranosyl Nucleosides
Patent: 6,870,048 →
Application: 10/112,403 →
Publication: US 2003/0060622
Method of Manufacture of 1,3-Oxathiolane Nucleosides
Patent: 6,939,965 →
Application: 10/361,980 →
Publication: US 2003/0144532
Combination Therapy to Treat Hepatitis B Virus
Patent: 7,572,800 →
Application: 10/374,363 →
Publication: US 2003/0158150
Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
Application: 10/618,531 →
Publication: US 2005/0196379
Method of Manufacture of 1,3-Oxathiolane Nucleosides
Application: 60/096,214 →
Non-Homogeneous Systems for the Resolution of Enantiomeric Mixtures
Application: 60/103,804 →
Combination Therapy to Treat Hepatitis B Virus
Application: 60/106,664 →
Method of Manufacture of 1,3-Oxathiolane Nucleosides
Application: 60/122,841 →
DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor
Application: 60/256,068 →
Polymorphic and other crystalline forms of FTC
Application: 60/272,560 →
DAPD combination therapy with ribavirin or mycophenolic acid
Application: 60/272,605 →
Sex non-specific methods and compositions for increasing bone mass
Application: 60/280,307 →
Polymorphic and other crystalline forms of cis-FTC
Application: 60/309,605 →
Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
Application: 60/396,117 →
2-Substituted-3-propenamide derivatives and methods of using the same
Application: 60/430,556 →
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 1998
From: FURMAN, PHILLIP A.; BARRY, DAVID W.; BORROTO-ESODA, KATYNA; MOXHAM, CARY P.
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 009335/0055 →
Assignment of Assignor's Interest Dec 23, 1998
From: LIOTTA, DENNIS; ALMOND, MERRICK; PAINTER, GEORGE; CLEARY, DARRYL
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 009658/0987 →
Assignment of Assignor's Interest Jun 21, 1999
From: FURMAN, PHILIP A.; PAINTER, GEORGE R.; BARRY, DAVID W.; ROUSSEAU, FRANCK
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 010030/0947 →
Security Interest Jul 16, 1999
From: ALTUS BIOLOGICS, INC.
To: TRANSAMERICA BUSINESS CREDIT CORP.
Reel/Frame 010086/0938 →
Assignment of Assignor's Interest Oct 1, 1999
From: PAINTER, GEORGE; LIOTTA, DENNIS; ALMOND, MERRICK; CLEARY, DARRYL
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 010285/0685 →
Assignment of Assignor's Interest Mar 14, 2002
From: FURMAN, PHILIP A.; BORROTO-ESODA, KATYNA
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 012724/0436 →
Assignment of Assignor's Interest Jul 16, 2002
From: PHARES, KENNETH R.
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 013090/0560 →
Assignment of Assignor's Interest Jul 16, 2002
From: LAW, DEVALINA; HU, YUERONG
To: ABBOTT LABORATORIES
Reel/Frame 013090/0569 →
Assignment of Assignor's Interest Jul 16, 2002
From: SZNAIDMAN, MARCOS
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 013096/0386 →
Assignment of Assignor's Interest Jan 13, 2003
From: LIOTTA, DENNIS C.; SORIA, JOSE
To: EMORY UNIVERSITY
Reel/Frame 013656/0927 →
Assignment of Assignor's Interest Jan 13, 2003
From: PAINTER, GEORGE; ALMOND MERRICK; CLEARY, DARRYL; SZNAIDMAN, MARCOS
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 013657/0873 →
Assignment of Assignor's Interest Feb 11, 2003
From: LIOTTA, DENNIS C.; SORIA, JOSE
To: EMORY UNIVERSITY
Reel/Frame 013768/0271 →
Assignment of Assignor's Interest Feb 11, 2003
From: PAINTER, GEORGE; ALMOND, MERRICK; CLEARY, DARRYL; SZNAIDMAN, MARCOS
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 013768/0285 →
Change of Name Jan 26, 2005
From: GILEAD SCIENCES, INC.
To: BUKWANG PHARMACEUTICAL IND CO., LTD.
Reel/Frame 015622/0881 →
Assignment of Assignor's Interest Sep 28, 2005
From: YAO, YIMING; WANG, YI FONG
To: ALTUS BIOLOGICS INC.
Reel/Frame 016845/0939 →
Change of Name Oct 21, 2005
From: ALTUS BIOLOGICS INC.
To: ALTUS PHARMACEUTICALS INC.
Reel/Frame 016924/0172 →
Assignment of Assignor's Interest Feb 7, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 029770/0125 →
Assignment of Assignor's Interest Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030176/0968 →